Late last month, the Association of Corporate Counsel (ACC) hosted a panel on artificial intelligence and how it is rapidly transforming the life sciences sector, allowing companies to leverage large datasets to accelerate...more
5/2/2024
/ Artificial Intelligence ,
Clinical Trials ,
Consent ,
EU ,
General Data Protection Regulation (GDPR) ,
Life Sciences ,
Personal Data ,
Pharmaceutical Industry ,
Privacy Notice Rule ,
Public Interest ,
Research and Development ,
Transparency